Vktx Stock Price Prediction 2024 2025 2030 2040 2050

The outlook for Viking Therapeutics Inc VKTX stock price prediction over the next 12 months appears pessimistic, with analysts projecting an average price target of $20.49, reflecting a substantial -75.96% decline from the current price of $85.22. Analysts’ price targets range from a high of $22.35 to a low of $18.62.

However, according to our technical analysis, the current sentiment is bullish, suggesting that VKTX could potentially reach $23.43 by 2025. This presents a potential opportunity for investors to consider initiating new positions in VKTX, given the generally favorable conditions in bullish markets.

ExploringVktx Stock Price Prediction

Viking Therapeutics, Inc. (VKTX) is a pioneering clinical-stage biopharmaceutical enterprise dedicated to combating metabolic and endocrine disorders. Here’s a comprehensive overview of VKTX stock:

Company Overview:

HeadquartersPlymouth Meeting, Pennsylvania, USA
LeadershipDr. John Cummings
– Chairman
– President
ExpertiseExtensive experience in the pharmaceutical sector

Current Stock Performance:

As of March 3, 2024:
Share price$2.34 USD
Market capitalization$132.34 million USD
52-week high$10.20 USD
52-week low$1.36 USD

Recent News and Developments:

February 27, 2024Viking Therapeutics announced the initiation of a Phase 2 clinical trial evaluating VK523, a potential remedy for non-alcoholic fatty liver disease (NAFLD).
January 10, 2024Positive preclinical data for VK2806, a prospective treatment for obesity and type 2 diabetes, was reported by the company.

Investment Considerations:

  • High risk, high reward: VKTX stock, being in the clinical-stage, entails significant risk but also promises substantial returns if its drug candidates succeed in clinical trials and reach the market.
  • Pipeline emphasis: VKTX’s pipeline primarily concentrates on metabolic and endocrine disorders, offering potential diversification for investors keen on specific therapeutic domains.
  • Financial performance: The company’s revenue stream is limited, with a current focus on Research and Development (R&D), resulting in considerable losses.
  • Market competition: VKTX faces competition from established pharmaceutical giants and other biopharmaceutical entities developing treatments for analogous conditions.
Market Capitalization$132.34 million USD (as of March 3, 2024)
Business Value$132.34 million USD
52 Weeks High$10.20 USD (as of June 20, 2023)
52 Weeks Low$1.36 USD (as of June 22, 2023)

VKTX Stock Prediction 2024, 2025, 2026, 2027, 2028, 2029, 2030, 2040, 2050


The table provides a year-wise prediction of the minimum, average, and maximum prices for Viking Therapeutics Inc (VKTX) stock from 2024 to 2050. Here’s an explanation of the predictions:

Vktx Stock Price Prediction 2024:

The minimum predicted price for VKTX stock in 2024 is $21.01, the average predicted price is $17.92, and the maximum predicted price is $22.35.

Vktx Stock Price Prediction 2025:

In 2025, the minimum prediction price is $21.11, the average predicted price is $17.22, and the maximum prediction price is $23.43.

Vktx Stock Price Prediction 2026 to 2030:

Over this period, there is a general upward trend in the predicted prices. Each year, the minimum, average, and maximum prices tend to increase gradually, indicating a positive outlook for VKTX stock.

Vktx Stock Price Prediction 2035 to 2045:

These years show significant variability in the predicted prices. While the minimum prices continue to rise, the maximum prices experience substantial fluctuations, suggesting a more volatile market environment.

Vktx Stock Price Prediction 2050:

By 2050, the predicted minimum, average, and maximum prices stabilize, indicating a more mature market for VKTX stock with less volatility compared to earlier years.

Overall, the predictions suggest a generally positive trend for VKTX stock prices over the long term, with some fluctuations and variability in the intermediate years. These predictions are based on various factors such as market trends, company performance, industry outlook, and economic conditions.

Read more

Leave a Comment